Merck Exec Says Co "Very Much Focused on the Second, Third-Generation Opportunities" in Cardiometabolic Drugs- Goldman Sachs Conf
默沙東高管表示公司非常關注心血管藥物的第二、三代機遇——高盛證券報告
Merck Exec Says Co "Very Much Focused on the Second, Third-Generation Opportunities" in Cardiometabolic Drugs- Goldman Sachs Conf
默沙東高管表示公司非常關注心血管藥物的第二、三代機遇——高盛證券報告
譯文內容由第三人軟體翻譯。